Bone Biologics
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income dropped to -$8,948,731 over the previous period. Total operating expenses were $9,428,303.

Profit Margin

Bone Biologics Corporation (NASDAQ:BBLGW): Profit margin
2014 0 -4.42M
2015 0 -13.87M
2016 0 -21.02M
2017 0 -7.05M
2018 0 -4.43M
2019 0 -3.42M
2020 0 -1.82M
2021 0 -1.61M
2022 0 695.93K
2023 0 -8.94M

BBLGW Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
0000000000
Cost of revenue
00005096967004.45K877.77K
Gross profit
0000-50-96-96-700-4.45K-877.77K
Operating exp.
Research and development
6.90M1.57M82.04K340.67K1.09M104.49K-1.19M11.60M3.66M623.52K
Selling and marketing
0000000000
Total operating expenses
9.42M3.66M1.10M825.01K2.44M2.79M2.62M17.84M11.99M3.01M
Operating income
-9.42M-3.66M-1.10M-825.01K-2.44M-2.79M-2.62M-17.84M-11.99M-3.01M
Other income (expenses), net
479.57K2.18M-507.60K-998.07K-975.77K-408.29K-4.42M-4.86K-1.87M-1.41M
Income before tax
-8.94M-1.48M-1.60M-1.82M-3.42M-4.42M-7.04M-21.02M-13.86M-4.42M
Income tax expense
0-2.18M1.6K1.6K1.60K1.72K1.6K2.24K8.84K1.6K
Net income
-8.94M695.93K-1.61M-1.82M-3.42M-4.43M-7.05M-21.02M-13.87M-4.42M
Earnings per share
Basic EPS
-34.0114.62-85.11-35.68-281.85-66.120-419.1300
Diluted EPS
-34.0114.62-85.11-35.68-281.85-66.120-419.1300
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source